Literature DB >> 10933516

Application of chrome azurol S for the extractive spectrophotometric determination of fluoxetine and fluvoxamine.

B Starczewska1, K Mielech.   

Abstract

Chrome azurol S has been tested as a spectrophotometric reagent for the determination of fluoxetine (FXT) and fluvoxamine (FXM). It reacts in aqueous media with FXT and FXM forming coloured, sparingly soluble in water compounds. These compounds can be quantitatively extracted with some organic solvents. This property has been exploited for the development of the extractive spectrophotometric methods for the determination of fluoxetine and fluvoxamine.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10933516     DOI： 10.1016/s0731-7085(00)00296-x

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN： 0731-7085            Impact factor:   3.935


  5 in total

1.  Spectroscopic and electrochemical analysis of psychotropic drugs.

Authors:  H Puzanowska-Tarasiewicz; W Misiuk; K Mielech-Łukasiewicz; L Kuźmicka
Journal:  Indian J Pharm Sci       Date:  2009-01       Impact factor: 0.975

2.  Spectrofluorimetric determination of fluvoxamine in dosage forms and plasma via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole.

Authors:  Ibrahim A Darwish; Sawsan M Amer; Heba H Abdine; Lama I Al-Rayes
Journal:  J Fluoresc       Date:  2008-10-23       Impact factor: 2.217

3.  Novel spectrophotometric method for determination of cinacalcet hydrochloride in its tablets via derivatization with 1,2-naphthoquinone-4-sulphonate.

Authors:  Ibrahim A Darwish; Mona M Al-Shehri; Manal A El-Gendy
Journal:  Chem Cent J       Date:  2012-02-03       Impact factor: 4.215

4.  New spectrophotometric and fluorimetric methods for determination of fluoxetine in pharmaceutical formulations.

Authors:  Ibrahim A Darwish; Sawsan M Amer; Heba H Abdine; Lama I Al-Rayes
Journal:  Int J Anal Chem       Date:  2009-08-16       Impact factor: 1.885

5.  Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid.

Authors:  Hamid Reza Akbari Hasanjani; Mahmoud Reza Sohrabi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.